Ybrain key facts
as of Oct 2026- Manufacturer of a wearable medical device intended to measure and treat neuropsychiatric illnesses based on neuroscience.
- Ybrain is valued at approximately $80.0M as of Oct 2026 (last reported valuation).
- It has raised $26.4M; the latest was Later Stage VC in Dec 2024.
- Notable investors include InterVest, STIC Ventures, Mirae Asset Global Investments, Ulmus Investment, LogInvestment — 21 tracked in total.
- Status: Privately Held (backing).
Ybrain's last reported valuation, Feb 2022. Nothing priced has surfaced since.
- ·The complete investor list: 21 names
- ·Watch Ybrain: the Monday email on marks, rounds and moves
Ybrain funding rounds
No funding rounds for Ybrain are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Ybrain
21+Membership and data by Private Market View
Ybrain valuation
Ybrain's last reported valuation was $80 million in Feb 2022. No priced round, secondary trade or fund mark has surfaced since.
Ybrain investors
21 investors are on record for Ybrain, including InterVest, STIC Ventures, Mirae Asset Global Investments and Ulmus Investment.
About Ybrain
Manufacturer of a wearable medical device intended to measure and treat neuropsychiatric illnesses based on neuroscience. The company's device is a wireless EEG system that permits operators to complete the preparation and collection of EEG signals and a non-invasive brain stimulation system that uses weak currents to stimulate the human brain, enabling medical professionals to treat Major Depressive Disorder and other psychiatric illnesses.
- Sector
- Healthcare
- HQ
- Seongnam, South Korea
- Founded
- 2013
- Employees
- 55
- Website
- ybrain.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.